These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7433850)

  • 61. The clinical use of synthetic 1,25-dihydroxycholecalciferol.
    Evans IM; Boulton-Jones M; Doyle FH; Joplin GF; Lockwood M; Matthews EW; MacIntyre I
    Calcif Tissue Res; 1976 Aug; 21 Suppl():236-41. PubMed ID: 782663
    [No Abstract]   [Full Text] [Related]  

  • 62. [Monstrous tumourous changes of the facial bones in secondary hyperparathyroidism (author's transl)].
    Pfeifle J; Koch H; Grabensee B; Knieriem HI
    Dtsch Med Wochenschr; 1974 Mar; 99(9):389-91. PubMed ID: 4828634
    [No Abstract]   [Full Text] [Related]  

  • 63. [Biochemical changes in patients with chronic renal insufficiency during hemodialysis depending on whether or not they received 25-(OH)D3].
    Rico H; Naranjo P; Paniagua MC; Cordero M; Bordiu E; Charro A
    Rev Clin Esp; 1982 Oct; 167(1):45-7. PubMed ID: 7178586
    [No Abstract]   [Full Text] [Related]  

  • 64. [Etiology of renal osteodystrophy].
    Ogura Y; Imamura H
    Nihon Rinsho; 1978 May; Suppl():2326-7. PubMed ID: 691748
    [No Abstract]   [Full Text] [Related]  

  • 65. Bone cysts in renal disease.
    Beal JM
    IMJ Ill Med J; 1973 Mar; 143(3):255-7 passim. PubMed ID: 4405759
    [No Abstract]   [Full Text] [Related]  

  • 66. [The clinical application of a chromatographic semiquantitative method for the determination of the vitamin-D level in blood (author's transl)].
    Weibbenbacher G; Washüttl J; Gemeiner M
    Wien Klin Wochenschr; 1973 Dec; 85(49):809-11. PubMed ID: 4356595
    [No Abstract]   [Full Text] [Related]  

  • 67. [Chronic renal insufficiency. A review of various clinical and physiopathological concepts].
    de Werra P
    Rev Med Suisse Romande; 1976 Sep; 96(9):651-8. PubMed ID: 968301
    [No Abstract]   [Full Text] [Related]  

  • 68. The red eye of renal failure: a crystal induced inflammation?
    Klaassen-Broekema N; van Bijsterveld OP
    Br J Ophthalmol; 1992 Oct; 76(10):578-81. PubMed ID: 1420037
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Densitometric studies by means of the photon absorption technic in renal osteopathy].
    Samizadeh A; Loew H; Losse H
    Verh Dtsch Ges Inn Med; 1978; (84):1113-5. PubMed ID: 741899
    [No Abstract]   [Full Text] [Related]  

  • 70. Blood pressure effects of acute hypercalcemia. Studies in patients with chronic renal failure.
    Weidmann P; Massry SG; Coburn JW; Maxwell MH; Atleson J; Kleeman CR
    Ann Intern Med; 1972 May; 76(5):741-5. PubMed ID: 5025324
    [No Abstract]   [Full Text] [Related]  

  • 71. [Surgical treatment of deformities of the lower extremities in hypophosphatemic renal osteopathy in children].
    Fishchenko PIa; Verdiev VG
    Ortop Travmatol Protez; 1977 Sep; (9):59-63. PubMed ID: 593675
    [No Abstract]   [Full Text] [Related]  

  • 72. Elevated phosphorus levels and risk of kidney disease.
    Mattana J; Shirazian S
    Am J Med; 2013 Oct; 126(10):e11. PubMed ID: 24054959
    [No Abstract]   [Full Text] [Related]  

  • 73. Phosphorus: another devil in our diet?
    Lien YH
    Am J Med; 2013 Apr; 126(4):280-1. PubMed ID: 23394866
    [No Abstract]   [Full Text] [Related]  

  • 74. Erythrocyte calcium in chronic renal failure.
    Udden MM
    Nephron; 1989; 51(4):573-4. PubMed ID: 2739842
    [No Abstract]   [Full Text] [Related]  

  • 75. Vitamin A toxicity and hypercalcaemia in chronic renal failure.
    O'Fearghail M; Walker JF; Cronin CJ
    Br Med J (Clin Res Ed); 1981 Oct; 283(6296):919. PubMed ID: 6793176
    [No Abstract]   [Full Text] [Related]  

  • 76. [Study of phosphorus and calcium metabolism in chronic renal insufficiency].
    Ulmann A
    Rev Prat; 1980 Sep; 30(39):2547-50. PubMed ID: 7433850
    [No Abstract]   [Full Text] [Related]  

  • 77. [Variations in serum levels of phosphorus (iP), calcium (Ca), calcitonin (iCT) and parathormone (iPTH) in patients under periodic hemodialysis. Effects of exogenous calcitonin therapy].
    Bucciante G; Bernardi A; Biasia F; Milan G; Donato D
    Minerva Med; 1985 Mar; 76(9-10):415-7. PubMed ID: 3982698
    [No Abstract]   [Full Text] [Related]  

  • 78. Target levels for serum phosphorus and parathyroid hormone.
    Qunibi W; Kalantar-Zadeh K
    Semin Dial; 2011; 24(1):29-33. PubMed ID: 21324001
    [No Abstract]   [Full Text] [Related]  

  • 79. [Effect of vitamin D metabolites on the markers of protein, calcium and phosphorus turnover in children with chronic renal failure].
    Denisova SN; Kutafina EK; Sergeeva TV; Savina MI; Kon' IIa; Shilina NM; Chizhevskaia OL; Shilov AV
    Vopr Pitan; 1998; (1):14-7. PubMed ID: 9606860
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Renal osteodystrophy in children with end-stage kidney failure.
    Chan JC
    Va Med; 1979 May; 106(5):384-90. PubMed ID: 463255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.